Estimating effectiveness in HIV prevention trials with a Bayesian hierarchical compound Poisson frailty model-Reference-Cited by-同舟云学术

Estimating effectiveness in HIV prevention trials with a Bayesian hierarchical compound Poisson frailty model

Published:2016-02-11 Issue:15 Volume:35 Page:2609-2634
ISSN:0277-6715
Container-title:Statistics in Medicine
language:en
Short-container-title:Statist. Med.

Author:

Coley Rebecca Yates¹,Brown Elizabeth R.¹²

Affiliation:

1. Department of Biostatistics; University of Washington; Seattle, WA U.S.A.

2. Fred Hutchinson Cancer Research Center; Seattle, WA U.S.A.

Funder

National Institute of Allergy and Infectious Diseases

Publisher

Wiley

Subject

Statistics and Probability,Epidemiology

Reference52 articles.

1. Joint United Nations Programme on HIV/AIDS Global report: UNAIDS report on the global AIDS epidemic: 2012 2013 http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2012/gr2012/20121120_UNAIDS_Global_Report_2012_with_annexes_en.pdf

2. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women;Karim;Science,2010

3. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women;Baeten;New England Journal of Medicine,2012

4. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana;Thigpen;New England Journal of Medicine,2012

5. PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial;McCormack;Lancet,2010

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Compound Poisson frailty model with a gamma process prior for the baseline hazard: accounting for a cured fraction;Journal of Applied Statistics;2021-07-05

2. Compound sum distributions with dependence;Statistics;2021-03-04

3. Joint modeling of time-varying HIV exposure and infection for estimation of per-act efficacy in HIV prevention trials;Statistical Communications in Infectious Diseases;2020-09-25

4. Bayesian modelling of zero‐inflated recurrent events and dependent termination with compound Poisson frailty model;Stat;2020-01

5. Crossover and Repeated Randomization in Event Driven Trials for HIV Prevention: Addressing the Impact of Heterogeneity in Risk in the Trial Design;Statistical Communications in Infectious Diseases;2019-07-12